Clinical trial

Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes

NCT01865305

Drugs and interventions used in this trial

9 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention insulin degludec/insulin aspart 30 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin degludec/insulin aspart 40 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin degludec/insulin aspart 50 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record insulin degludec Normalized identity: insulin degludecView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin aspart Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention biphasic insulin aspart 30 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin degludec/insulin aspart 40 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin degludec/insulin aspart 50 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention biphasic insulin aspart 30 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE1

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

insulin degludec/insulin aspart 30DRUG

insulin degludec/insulin aspart 40DRUG

insulin degludec/insulin aspart 50DRUG

insulin degludecDRUG · verified · RxNorm: insulin degludec

insulin aspartDRUG

biphasic insulin aspart 30DRUG

insulin degludec/insulin aspart 40DRUG

insulin degludec/insulin aspart 50DRUG

biphasic insulin aspart 30DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01865305 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.